Immunogenic cell death is a rare form of immunostimulatory cell death that can reactivate tumor-specific immune responses and is characterized by the release of DAMPs, including exposure to CRT on the cell surface and release of ATP and HMGB1 [23]. This evidence concerns the gene HMGB1 and neoplasm.